Zeteo Biomedical has announced the launch of its ZEOx1 OrionMRQ metered dose nasal device for delivery of drugs and vaccines. Zeteo’s ZEOx1 devices are designed for intranasal delivery of liquid formulations, and its ZEOx2 devices are designed for intranasal delivery of powders, reconstituted powders, or multiple liquid formulations. In November 2020, Zeteo said that Iowa State University had selected the company‘s ZEOx2 nasal delivery system for use with a SARS-CoV-2 vaccine.
According to Zeteo, the OrionMRQ can be configured for use by adults or children. The device is reloadable and includes a storage compartment for up to four doses packaged in unit dose blisters.
Read the Zeteo Biomedical press release.
